Amgen Seeking ESA Dosing Algorithm As Scripts Continue To Fall In Oncology

Amgen is taking steps to construct dosing algorithms for its erythropoiesis-stimulating agents that may help mitigate problems stemming from heterogeneous patient response to the anemia therapies